Zimmer Biomet Holdings (ZBH) Tops Q2 EPS by 1c, raises guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Zimmer Biomet's (ZBH) strong second quarter tarnished by high expectations
August 1, 2023 12:13 PM EDTShares of medical technology company Zimmer Biomet (NYSE: ZBH) declined after it reported results for the second quarter of 2023. Revenue, earnings per share, and guidance all topped published consensus figures but they were still not enough to meet elevated expectations on Wall Street.
Zimmer Biomet reported second quarter EPS of 1.82, a... More
